emtricitabine
IP standards
- Emtricitabine is a drug which is used for the treatment of HIV and a nucleoside reverse transcriptase inhibitor (NRTI). It shows activity against hepatitis B virus (HBV). An analog of cytidine and inhibits reverse transtriptase. Reference standards of Emtricitabine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Emtricitabine (IPRS/34/13)-from IPC
[catalogue_number] => PA IPIPRS 34 13
[category_ids] => ,151,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => emtricitabine-iprs-34-13-paipiprs3413
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Emtricitabine (IPRS/34/13)-from IPC
stdClass Object
(
[pname] => Emtricitabine Racemic Mixture (IMP/07/20)
[catalogue_number] => PA IMP 07 20
[category_ids] => ,151,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => emtricitabine-racemic-mixture-imp-07-20-paimp0720
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Emtricitabine Racemic Mixture (IMP/07/20)
